sermorelin and semaglutide together A Scientific Look at Combining with GLP-1s like & Tirzepatide Semaglutide

Perry TL, Hansen S, Jones K

Pharmacologically, signaling studies demonstrate that tirzepatide mimics the actions of native GIP at the GIP receptor but shows bias at the GLP-1 receptor to favor cAMP generation over -arrestin recruitment, coincident with a weaker ability to drive GLP-1 receptor internalization compared with GLP-1

However, each study approached this improvement from a unique perspective, interpreting cardiovascular benefits through different measures

After this period, the dose may be raised by a doctor based on individual needs, with common increments leading up to a potential maximum of 2 mg each week